JUL 22, 2019 2:39 PM PDT

New Freezing Technique for Breast Cancer Patients in Low Income Countries

WRITTEN BY: Julia Travers

Treatment for breast cancer can be too expensive and hard to access for many women in lower-income countries. These women are disproportionately affected by breast cancer and experience a higher related mortality rate. In the United States, more than 90 percent of women survive breast cancer. But in countries like The Gambia, Saudi Arabia or Uganda, survival rates are much lower, ranging from about 12 to 64 percent.

A student-led research team of the Biomedical Engineering Design Program at Johns Hopkins University is creating a novel approach to bringing successful treatment to more breast cancer patients around the world. Many of these women cannot afford or reach procedures like chemotherapy, radiation and surgery. Cryoablation, or killing cancerous tissue by freezing it, can be preferable because it does not require an operating room or anesthesia and so can be performed in community clinics.

This technique typically uses argon gas, which can cost as much as $10,000 per treatment and can be hard to come by in many parts of the world. The Johns Hopkins team used carbon dioxide instead, which is much cheaper and easier to find. According to EurekAlert, they tested this procedure in three experiments that mimicked the temperatures and conditions of human breasts, finding it could successfully kill tumor tissue. The three test materials or environments were ultrasound gel, rats with mammary tumors and the normal liver of a pig. The device met standard freezing temperatures for tissue death for similar U.S. devices and killed at least 85 percent of the tumor tissue.

"Innovation in cancer care doesn't always mean you have to create an entirely new treatment, sometimes it means radically innovating on proven therapies such that they're redesigned to be accessible to the majority of the world's population," Bailey Surtees, the study's first author and a Johns Hopkins University biomedical engineering graduate, said. The researchers now plan to continue testing the device for use with people and also hope to broaden its application to pets. Their findings were published in July 2019 in PLOS One.

 

An animation of the procedure is below:

 

 

Source: EurekAlert

 
About the Author
  • Julia Travers is a writer, artist and teacher. She frequently covers science, tech, conservation and the arts. She enjoys solutions journalism. Find more of her work at jtravers.journoportfolio.com.
You May Also Like
JUN 11, 2021
Cancer
Man beats brain cancer with ketogenic diet
JUN 11, 2021
Man beats brain cancer with ketogenic diet
Glioblastoma brain cancer continues to be one of the most fatal cancers, responsible for approximately 15,000 death ever ...
JUL 23, 2021
Cancer
New Drug Eradicates Breast Cancer Tumors in Days
JUL 23, 2021
New Drug Eradicates Breast Cancer Tumors in Days
A new drug can kill between 95 and 100% of cancer cells in mice with human estrogen-receptor-positive breast cancer. The ...
AUG 01, 2021
Genetics & Genomics
Rethinking the Cause of Mutations That Lead to Melanoma
AUG 01, 2021
Rethinking the Cause of Mutations That Lead to Melanoma
Throughout our lives, new cells often replace the ones that become damaged or worn out. As cells divide, they have to re ...
AUG 07, 2021
Cancer
New Drug Combo Eliminates Pancreatic Cancer in Mice
AUG 07, 2021
New Drug Combo Eliminates Pancreatic Cancer in Mice
A combination of three immunotherapy drugs can eliminate pancreatic tumors in mice. The study was published in Canc ...
SEP 13, 2021
Cancer
Fat Loss can Predict Gastric Cancer Survival
SEP 13, 2021
Fat Loss can Predict Gastric Cancer Survival
Cancer cachexia is a metabolic disorder in cancer patients experiencing uncontrolled weight loss.  While cancer cac ...
SEP 20, 2021
Cancer
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
SEP 20, 2021
An Established Ovarian Cancer Antigen Presents a Promising Therapeutic Target
For the past several decades, cancer antigen 125 (CA 125), a protein located on the surface of ovarian cancer cells, has ...
Loading Comments...